Topical vs Oral Metronidazole After Benign Anorectal Surgery

Sponsor
Mansoura University (Other)
Overall Status
Completed
CT.gov ID
NCT05038605
Collaborator
(none)
108
1
3
13.2
8.2

Study Details

Study Description

Brief Summary

While some investigators found oral metronidazole to be effective in reducing pain after hemorrhoidectomy, other researchers did not find a significant analgesic effect of systemic metronidazole. On the other hand, topical application of metronidazole had more consistent favorable results as Ala et al documented a remarkable analgesic effect of topical metronidazole 10% after excisional hemorrhoidectomy which was in line with Nicholson and Armestrong who also concluded similar results.

No previous study compared the analgesic effect of topical and oral metronidazole after anorectal surgery. Therefore, the present trial was conducted to compare the impact of oral versus systemic metronidazole on pain and recovery after surgery for benign anorectal conditions.

Condition or Disease Intervention/Treatment Phase
  • Drug: Topical metronidazole
  • Drug: oral metronidazole
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
108 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Topical Versus Oral Metronidazole for Pain Relief After Surgery for Benign Anorectal Conditions; a Prospective Randomized Study
Actual Study Start Date :
Jan 24, 2020
Actual Primary Completion Date :
Jan 30, 2021
Actual Study Completion Date :
Mar 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Topical metronidazole

Topical application of metronidazole cream on the anal verge after surgery

Drug: Topical metronidazole
Topical application of metronidazole cream on the anal verge every 8 hours after surgery

Active Comparator: Oral metronidazole

oral metronidazole 500 mg tablets after surgery

Drug: oral metronidazole
Patients received oral metronidazole 500 mg tablets every 8 hours after surgery

No Intervention: Control

No metronidazole was received

Outcome Measures

Primary Outcome Measures

  1. Postoperative pain score [at one day after surgery]

    Pain was assessed using visual analogue scale form 0 to 10, higher score indicates worse pain

  2. Postoperative pain score [at two days after surgery]

    Pain was assessed using visual analogue scale form 0 to 10, higher score indicates worse pain

  3. Postoperative pain score [at seven days after surgery]

    Pain was assessed using visual analogue scale form 0 to 10, higher score indicates worse pain

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients of either sex aged below 70 years

  • Underwent surgery for hemorrhoids, anal fissure, or simple anal fistula.

Exclusion Criteria:
  • Grade I-II hemorrhoids.

  • acute anal fissure.

  • complex anal fistula

  • perianal abscess

  • perianal Crohn's disease

  • malignancy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mansoura university hospital Mansourah Dakahlia Egypt 35516

Sponsors and Collaborators

  • Mansoura University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sameh Emile, Associate professor of surgery, Mansoura University
ClinicalTrials.gov Identifier:
NCT05038605
Other Study ID Numbers:
  • Mansoura2021
First Posted:
Sep 9, 2021
Last Update Posted:
Sep 9, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 9, 2021